Novo Nordisk is predicted to achieve sustained long-term expansion despite short-term market challenges.
"The market may be focused on short-term challenges, but the long-term trajectory points to sustained expansion, making Novo Nordisk one of the most resilient and strategically positioned players in global pharma today."
